2015–16 Zika virus epidemic

The 2015–16 Zika virus epidemic was a significant outbreak of the Zika virus that occurred in various regions across the globe during the years 2015 and 2016. The epidemic raised concerns due to the potential health risks associated with the virus, particularly its link to birth defects such as microcephaly.
Background[edit]
The Zika virus is a mosquito-borne virus that is primarily transmitted by Aedes aegypti mosquitoes. The virus was first identified in monkeys in Uganda in 1947 and later in humans in 1952. Prior to the 2015–16 epidemic, Zika outbreaks were relatively small and confined to specific regions.
Spread and Impact[edit]
The 2015–16 Zika virus epidemic gained international attention as the virus spread rapidly to various countries in the Americas, including Brazil, Colombia, and Venezuela. The epidemic was characterized by a surge in reported cases of Zika virus infection, particularly among pregnant women.
One of the most concerning aspects of the epidemic was the potential link between Zika virus infection during pregnancy and the development of microcephaly in infants. Microcephaly is a birth defect characterized by an abnormally small head and brain size, which can lead to developmental delays and other neurological complications.
Response and Containment[edit]
In response to the epidemic, various public health organizations and governments implemented measures to control the spread of the virus. Efforts focused on mosquito control, public awareness campaigns, and research into potential vaccines and treatments for Zika virus infection.
Legacy[edit]
The 2015–16 Zika virus epidemic highlighted the importance of global cooperation in addressing emerging infectious diseases. The epidemic also underscored the need for continued research into the prevention and treatment of Zika virus infection, particularly in vulnerable populations such as pregnant women.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
